Annual Net Income:
-$234.33M-$51.94M(-28.48%)Summary
- As of today, XENE annual net profit is -$234.33 million, with the most recent change of -$51.94 million (-28.48%) on December 31, 2024.
- During the last 3 years, XENE annual net income has fallen by -$155.45 million (-197.06%).
- XENE annual net income is now -1900.05% below its all-time high of $13.02 million, reached on December 31, 2014.
Performance
XENE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$84.71M-$19.66M(-30.22%)Summary
- As of today, XENE quarterly net profit is -$84.71 million, with the most recent change of -$19.66 million (-30.22%) on June 1, 2025.
- Over the past year, XENE quarterly net income has dropped by -$26.78 million (-46.24%).
- XENE quarterly net income is now -998.93% below its all-time high of $9.42 million, reached on December 31, 2014.
Performance
XENE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$278.23M-$26.78M(-10.65%)Summary
- As of today, XENE TTM net profit is -$278.23 million, with the most recent change of -$26.78 million (-10.65%) on June 1, 2025.
- Over the past year, XENE TTM net income has dropped by -$79.17 million (-39.77%).
- XENE TTM net income is now -1881.12% below its all-time high of $15.62 million, reached on December 31, 2014.
Performance
XENE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
XENE Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -28.5% | -46.2% | -39.8% |
| 3Y3 Years | -197.1% | -171.9% | -203.0% |
| 5Y5 Years | -463.4% | -10000.0% | -897.6% |
XENE Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -197.1% | at low | -128.0% | at low | -145.0% | at low |
| 5Y | 5-Year | -712.6% | at low | -856.6% | at low | -897.6% | at low |
| All-Time | All-Time | -1900.0% | at low | -998.9% | at low | -1881.1% | at low |
XENE Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$84.71M(-30.2%) | -$278.23M(-10.7%) |
| Mar 2025 | - | -$65.05M(+1.0%) | -$251.45M(-7.3%) |
| Dec 2024 | -$234.33M(-28.5%) | -$65.69M(-4.6%) | -$234.33M(-9.8%) |
| Sep 2024 | - | -$62.79M(-8.4%) | -$213.39M(-7.2%) |
| Jun 2024 | - | -$57.92M(-20.8%) | -$199.06M(-5.5%) |
| Mar 2024 | - | -$47.93M(-7.1%) | -$188.60M(-3.4%) |
| Dec 2023 | -$182.39M(-45.5%) | -$44.74M(+7.7%) | -$182.39M(-4.2%) |
| Sep 2023 | - | -$48.46M(-2.1%) | -$175.04M(-6.9%) |
| Jun 2023 | - | -$47.46M(-13.7%) | -$163.73M(-11.1%) |
| Mar 2023 | - | -$41.73M(-11.6%) | -$147.43M(-17.6%) |
| Dec 2022 | -$125.37M(-58.9%) | -$37.40M(-0.7%) | -$125.37M(-10.4%) |
| Sep 2022 | - | -$37.15M(-19.2%) | -$113.54M(-23.6%) |
| Jun 2022 | - | -$31.16M(-58.4%) | -$91.84M(-10.9%) |
| Mar 2022 | - | -$19.67M(+23.1%) | -$82.79M(-5.0%) |
| Dec 2021 | -$78.88M(-173.5%) | -$25.56M(-65.5%) | -$78.88M(-20.2%) |
| Sep 2021 | - | -$15.45M(+30.1%) | -$65.64M(-11.2%) |
| Jun 2021 | - | -$22.11M(-40.2%) | -$59.05M(-59.1%) |
| Mar 2021 | - | -$15.76M(-27.9%) | -$37.12M(-28.7%) |
| Dec 2020 | -$28.84M(+30.7%) | -$12.32M(-39.2%) | -$28.84M(-3.4%) |
| Sep 2020 | - | -$8.86M(-4960.0%) | -$27.89M(+0.1%) |
| Jun 2020 | - | -$175.00K(+97.7%) | -$27.91M(+26.1%) |
| Mar 2020 | - | -$7.48M(+34.2%) | -$37.74M(+9.3%) |
| Dec 2019 | -$41.59M | -$11.38M(-28.2%) | -$41.59M(-7.3%) |
| Sep 2019 | - | -$8.87M(+11.4%) | -$38.78M(+12.4%) |
| Jun 2019 | - | -$10.01M(+11.8%) | -$44.29M(-5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$11.34M(-32.5%) | -$42.08M(-22.0%) |
| Dec 2018 | -$34.50M(-12.4%) | -$8.56M(+40.5%) | -$34.50M(-1.4%) |
| Sep 2018 | - | -$14.38M(-84.4%) | -$34.00M(-24.3%) |
| Jun 2018 | - | -$7.80M(-107.7%) | -$27.36M(-1.6%) |
| Mar 2018 | - | -$3.75M(+53.4%) | -$26.94M(+12.3%) |
| Dec 2017 | -$30.70M(-33.5%) | -$8.06M(-4.2%) | -$30.70M(-7.2%) |
| Sep 2017 | - | -$7.74M(-4.9%) | -$28.64M(-0.1%) |
| Jun 2017 | - | -$7.38M(+1.8%) | -$28.61M(-5.0%) |
| Mar 2017 | - | -$7.52M(-25.2%) | -$27.25M(-18.5%) |
| Dec 2016 | -$23.00M(-46.0%) | -$6.00M(+22.2%) | -$23.00M(-9.9%) |
| Sep 2016 | - | -$7.71M(-28.2%) | -$20.93M(-22.8%) |
| Jun 2016 | - | -$6.02M(-84.4%) | -$17.04M(-72.9%) |
| Mar 2016 | - | -$3.26M(+17.1%) | -$9.86M(+8.9%) |
| Dec 2015 | -$15.75M(-221.0%) | -$3.94M(-2.9%) | -$10.82M(-526.2%) |
| Sep 2015 | - | -$3.83M(-427.7%) | $2.54M(-74.5%) |
| Jun 2015 | - | $1.17M(+127.6%) | $9.96M(-0.6%) |
| Mar 2015 | - | -$4.22M(-144.8%) | $10.02M(-35.8%) |
| Dec 2014 | $13.02M(+239.6%) | $9.42M(+162.1%) | $15.62M(+79.3%) |
| Sep 2014 | - | $3.60M(+192.3%) | $8.71M(-24.2%) |
| Jun 2014 | - | $1.23M(-10.4%) | $11.49M(+12.0%) |
| Mar 2014 | - | $1.37M(-45.4%) | $10.27M(+15.4%) |
| Dec 2013 | $3.83M(+189.1%) | $2.51M(-60.6%) | $8.89M(+39.4%) |
| Sep 2013 | - | $6.38M | $6.38M |
| Dec 2012 | -$4.30M(+64.1%) | - | - |
| Dec 2011 | -$11.99M | - | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual net profit?
- What is the all-time high annual net income for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual net income year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly net profit?
- What is the all-time high quarterly net income for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly net income year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM net profit?
- What is the all-time high TTM net income for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM net income year-on-year change?
What is Xenon Pharmaceuticals Inc. annual net profit?
The current annual net income of XENE is -$234.33M
What is the all-time high annual net income for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual net profit is $13.02M
What is Xenon Pharmaceuticals Inc. annual net income year-on-year change?
Over the past year, XENE annual net profit has changed by -$51.94M (-28.48%)
What is Xenon Pharmaceuticals Inc. quarterly net profit?
The current quarterly net income of XENE is -$84.71M
What is the all-time high quarterly net income for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly net profit is $9.42M
What is Xenon Pharmaceuticals Inc. quarterly net income year-on-year change?
Over the past year, XENE quarterly net profit has changed by -$26.78M (-46.24%)
What is Xenon Pharmaceuticals Inc. TTM net profit?
The current TTM net income of XENE is -$278.23M
What is the all-time high TTM net income for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM net profit is $15.62M
What is Xenon Pharmaceuticals Inc. TTM net income year-on-year change?
Over the past year, XENE TTM net profit has changed by -$79.17M (-39.77%)